Prelude Therapeutics Incorporated PRLD
$4.87
+6.56%
at last close
Financials (TTM)
- Revenue
- $22.42 million
- Net Income
- $-60,488,000
- Net Margin
- -269.75%
- Return on Equity
- -45.23%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 2.91
- Price / Sales
- 17.33
Over the trailing twelve months, Prelude Therapeutics Incorporated generated revenue of $22.42 million and net income of $-60,488,000, a net margin of -269.75%.
At the last closing price of $4.87, PRLD trades at 17.33 times sales, with a market capitalization of $388.64 million.
Key Stats
- Last Close
- $4.87
- Market Cap
- $388.64 million
- 52-Week Range
- $0.82 – $6.83
- Average Volume
- 538K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.